A Subdominant CD8+ Cytotoxic T Lymphocyte (CTL) Epitope from the Plasmodium yoeliiCircumsporozoite Protein Induces CTLs That Eliminate Infected Hepatocytes from Culture
暂无分享,去创建一个
Alessandro Sette | Scott Southwood | Stephen L. Hoffman | S. Hoffman | A. Sette | J. Sacci | E. Franke | S. Southwood | G. Corradin | Giampietro Corradin | Eileen D. Franke | John Sacci
[1] Richard Graham Knowles,et al. 1400W Is a Slow, Tight Binding, and Highly Selective Inhibitor of Inducible Nitric-oxide Synthase in Vitro and in Vivo* , 1997, The Journal of Biological Chemistry.
[2] Division on Earth. Guide for the Care and Use of Laboratory Animals , 1996 .
[3] M. Tsuji,et al. Plasmodium yoelii: peptide immunization induces protective CD4+ T cells against a previously unrecognized cryptic epitope of the circumsporozoite protein. , 1996, Experimental parasitology.
[4] Lunli Yuan,et al. Comparison of cytotoxic T lymphocyte responses induced by peptide or DNA immunization: Implications on immunogenicity and immunodominance , 1997, European journal of immunology.
[5] D. Valmori,et al. Presentation of T-cell epitopes assembled as multiple-antigen peptides to murine and human T lymphocytes , 1993, Infection and immunity.
[6] L. Rénia,et al. Linear and multiple antigen peptides containing defined T and B epitopes of the Plasmodium yoelii circumsporozoite protein: antibody-mediated protection and boosting by sporozoite infection. , 1997, International immunology.
[7] S. Hoffman,et al. Induction of murine cytotoxic T lymphocytes against Plasmodium falciparum sporozoite surface protein 2 , 1994, European journal of immunology.
[8] L. Rénia,et al. In vitro activity of CD4+ and CD8+ T lymphocytes from mice immunized with a synthetic malaria peptide. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[9] S. Hoffman,et al. Induction of protective CTL responses against the Plasmodium yoelii circumsporozoite protein by immunization with peptides. , 1997, Journal of immunology.
[10] A. Vitiello,et al. Immunodominance analysis of CTL responses to influenza PR8 virus reveals two new dominant and subdominant Kb-restricted epitopes. , 1996, Journal of immunology.
[11] S. Hoffman,et al. Circumventing genetic restriction of protection against malaria with multigene DNA immunization: CD8+ cell-, interferon gamma-, and nitric oxide-dependent immunity , 1996, The Journal of experimental medicine.
[12] P. Romero,et al. H-2Kd-restricted antigenic peptides share a simple binding motif , 1991, The Journal of experimental medicine.
[13] L. Rénia,et al. Immune responses to defined epitopes of the circumsporozoite protein of the murine malaria parasite, Plasmodium yoelii , 1990, European journal of immunology.
[14] D. Valmori,et al. Immunodominance of cytotoxic T lymphocyte epitopes co‐injected in vivo and modulation by interleukin‐12 , 1996, European journal of immunology.
[15] M. Selby,et al. Cationic lipids direct a viral glycoprotein into the class I major histocompatibility complex antigen-presentation pathway. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[16] L. Rénia,et al. Effector functions of circumsporozoite peptide-primed CD4+ T cell clones against Plasmodium yoelii liver stages. , 1993, Journal of immunology.
[17] V. Nussenzweig,et al. Multiple T helper cell epitopes of the circumsporozoite protein of Plasmodium berghei , 1988, European journal of immunology.
[18] L. Rénia,et al. Peptide-primed CD4+ cells and malaria sporozoites. , 1990, Immunology letters.
[19] H. Rammensee,et al. In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine , 1989, Nature.
[20] P. Palese,et al. Priming with recombinant influenza virus followed by administration of recombinant vaccinia virus induces CD8+ T-cell-mediated protective immunity against malaria. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[21] M. Bawden,et al. Rapid, large-scale isolation of Plasmodium berghei sporozoites from infected mosquitoes. , 1979, The Journal of parasitology.
[22] J. Sidney,et al. Analysis of cytotoxic T cell responses to dominant and subdominant epitopes during acute and chronic lymphocytic choriomeningitis virus infection. , 1996, Journal of immunology.
[23] A Sette,et al. Melanoma-specific CD4+ T cells recognize nonmutated HLA-DR-restricted tyrosinase epitopes , 1996, The Journal of experimental medicine.
[24] A Sette,et al. The relation between major histocompatibility complex (MHC) restriction and the capacity of Ia to bind immunogenic peptides , 1987, Science.
[25] M. Torres,et al. Nomenclature for factors of the HLA system. , 2011, Bulletin of the World Health Organization.
[26] A. Sette,et al. Recognition of multiple epitopes in the human melanoma antigen gp100 by tumor-infiltrating T lymphocytes associated with in vivo tumor regression. , 1995, Journal of immunology.
[27] A Sette,et al. Role of HLA-A motifs in identification of potential CTL epitopes in human papillomavirus type 16 E6 and E7 proteins. , 1994, Journal of immunology.
[28] A Sette,et al. Improved induction of melanoma-reactive CTL with peptides from the melanoma antigen gp100 modified at HLA-A*0201-binding residues. , 1996, Journal of immunology.
[29] H. Grey,et al. Epitope selection and development of peptide based vaccines to treat cancer. , 1995, Seminars in cancer biology.
[30] H. Schild,et al. Efficiency of peptides and lipopeptides for in vivo priming of virus‐specific cytotoxic T cells , 1991, European journal of immunology.
[31] S. Hoffman,et al. Evaluation of an in vitro assay aimed at measuring protective antibodies against sporozoites. , 1990, Bulletin of the World Health Organization.
[32] H. Grey,et al. Structural analysis of peptides capable of binding to more than one Ia antigen. , 1989, Journal of immunology.
[33] Antonio Lanzavecchia,et al. Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells , 1989, European journal of immunology.
[34] B. Nardelli,et al. Cellular immune responses induced by in vivo priming with a lipid-conjugated multimeric antigen peptide. , 1993, Immunology.
[35] W R Mayr,et al. Nomenclature for factors of the HLA system, 1994. , 1994, Vox sanguinis.
[36] P. Migliorini,et al. Malaria vaccine: Immunization of mice with a synthetic T cell helper epitope alone leads to protective immunity , 1993, European journal of immunology.
[37] S. Hoffman,et al. Pan DR binding sequence provides T-cell help for induction of protective antibodies against Plasmodium yoelii sporozoites. , 1999, Vaccine.
[38] S. Hoffman,et al. Plasmodium yoelii: 17-kDa hepatic and erythrocytic stage protein is the target of an inhibitory monoclonal antibody. , 1995, Experimental parasitology.
[39] R. Houghten,et al. Peptide immunization can elicit malaria protein-specific memory helper but not proliferative T cells. , 1990, Peptide research.
[40] A. Vitiello,et al. Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. I. Induction of a primary cytotoxic T lymphocyte response in humans. , 1995, The Journal of clinical investigation.
[41] P. Romero,et al. T helper epitopes enhance the cytotoxic response of mice immunized with MHC class I-restricted malaria peptides. , 1992, Journal of immunological methods.
[42] A. Miller,et al. Dominance and crypticity of T cell antigenic determinants. , 1993, Annual review of immunology.
[43] S. Hoffman,et al. Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[44] T. Wolfle. Institute of Laboratory Animal Resources. , 1995 .
[45] W. Ballou,et al. Distinct T cell specificities are induced with the authentic versus recombinant Plasmodium berghei circumsporozoite protein. , 1992, Journal of immunology.
[46] A Sette,et al. Practical, biochemical and evolutionary implications of the discovery of HLA class I supermotifs. , 1996, Immunology today.